Suppr超能文献

定性分析腹腔透析液中多糖降解产物。

Qualitative Profiling of Polyglucose Degradation Products in Peritoneal Dialysis Fluids.

机构信息

†Food Chemistry Unit, Department of Chemistry and Pharmacy, Emil Fischer Center, Friedrich-Alexander Universität Erlangen-Nürnberg (FAU), Schuhstr. 19, 91052 Erlangen, Germany.

‡Medicinal Chemistry Unit, Department of Chemistry and Pharmacy, Emil Fischer Center, Friedrich-Alexander Universität Erlangen-Nürnberg (FAU), Schuhstr. 19, 91052 Erlangen, Germany.

出版信息

Anal Chem. 2015 Jun 16;87(12):6103-11. doi: 10.1021/acs.analchem.5b00665. Epub 2015 May 22.

Abstract

Heat sterilization of peritoneal dialysis (PD) fluids leads to partial degradation of the osmotic agent to form reactive carbonyl structures, which significantly reduce the biocompatibility of PD fluids and impair long-term PD therapy. Hence, it is important to know the exact composition of the degradation products to improve biocompatibility of PD fluids. Our study conducted targeted screening for degradation products in polyglucose (icodextrin)-containing PD fluids (pGDPs) by applying o-phenylenediamine (OPD) to form stable derivatives, which were analyzed by ultrahigh-performance liquid chromatography with hyphenated diode array tandem mass spectrometry (UHPLC-DAD-MS/MS). For the first time, specific degradation products of polyglucose, namely, 4-deoxyglucosone (4-DG) and 3,4-dideoxypentosone (3,4-DDPS), could be identified in PD fluids. Further, a reaction product of 5-hydroxymethylfurfural (5-HMF) and OPD could be characterized to be (5-(1H-benzo[d]imidazol-2-yl)furan-2-yl)methanol. Additionally, 3-deoxyglucosone (3-DG) and 3-deoxygalactosone (3-DGal), both known to be present in glucose-based PD fluids, were also detected in polyglucose-containing fluids. Trapping a hitherto unknown degradation product with OPD yielded 1,4-bis(1H-benzo[d]imidazol-2-yl)-3,4-dihydroxybutan-1-one, which was present in heat- as well as filter-sterilized PD fluids.

摘要

聚葡萄糖(艾考糊精)腹膜透析液的热消毒会导致渗透剂部分降解,形成反应性羰基结构,这显著降低了腹膜透析液的生物相容性,并损害了长期的腹膜透析治疗。因此,了解降解产物的确切组成对于提高腹膜透析液的生物相容性非常重要。我们的研究通过应用邻苯二胺(OPD)形成稳定的衍生物,对含有聚葡萄糖的腹膜透析液(pGDP)中的降解产物进行了靶向筛选,然后通过超高效液相色谱与二极管阵列串联质谱(UHPLC-DAD-MS/MS)进行分析。我们首次在 PD 液中鉴定出聚葡萄糖的特定降解产物,即 4-脱氧葡萄糖(4-DG)和 3,4-二脱氧戊糖酮(3,4-DDPS)。此外,还可以表征 OPD 与 5-羟甲基糠醛(5-HMF)的反应产物为(5-(1H-苯并[d]咪唑-2-基)呋喃-2-基)甲醇。此外,在含有聚葡萄糖的液体中还检测到 3-脱氧葡萄糖(3-DG)和 3-脱氧半乳糖酮(3-DGal),这两种物质都已知存在于葡萄糖基 PD 液中。用 OPD 捕获一种迄今未知的降解产物生成 1,4-双(1H-苯并[d]咪唑-2-基)-3,4-二羟基丁-1-酮,它存在于热消毒和过滤消毒的 PD 液中。

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验